Literature DB >> 441922

Effect of a calcium antagonist on experimental constriction of human brain vessels.

L Edvinsson, L Brandt, K E Andersson, B Bengtsson.   

Abstract

In search for a potent dilatator or deactivator of constriction of cerebrovascular smooth muscle, the effects of a specific antagonist of the calcium influx necessary for the excitation-contraction coupling process was studied on isolated human pial arteries. The arteries were constricted by addition of noradrenaline, 5-hydroxytryptamine, human plasma or blood. All these agents induced a strong contraction which could effectively be reduced by addition of the Ca++-antagonist, nifedipine, to the organ bath. It is suggested that calcium antagonists might be of value in the treatment of cerebrovascular spasm following a subarachnoid hemorrhage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 441922

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  11 in total

Review 1.  Vascular headache.

Authors:  K L Kumar; T G Cooney
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

2.  Experimental basilar artery spasm caused by autologous blood application: effects of clot removal and topical nicardipine.

Authors:  R Tuncer
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

3.  Calcium blockers for cardiac disease: therapeutic implications.

Authors:  A Dodek; J Ruedy
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

4.  Protein therapy using heme-oxygenase-1 fused to a polyarginine transduction domain attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.

Authors:  Tomoyuki Ogawa; Daniel Hänggi; Yumei Wu; Hiroyuki Michiue; Kazuhito Tomizawa; Shigeki Ono; Hideki Matsui; Isao Date; Hans-Jakob Steiger
Journal:  J Cereb Blood Flow Metab       Date:  2011-06-08       Impact factor: 6.200

5.  Local cerebral glucose utilization and local cerebral blood flow in conscious rats after administration of flunarizine.

Authors:  T Beck; J Krieglstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

6.  Calcium antagonists: effects on cerebral blood flow and blood-brain barrier permeability in the rat.

Authors:  L Edvinsson; B B Johansson; B Larsson; E T MacKenzie; T Skärby; A R Young
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

7.  Reduction of cellular damage induced by cerebral ischemia in rats.

Authors:  A W Leung; Z X Mo; Y S Zheng
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

8.  Hypercalcaemia associated with cerebral vasospasm causing infarction.

Authors:  G L Walker; P M Williamson; R B Ravich; J Roche
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-05       Impact factor: 10.154

9.  Calcium ions and calcium antagonists in ischaemia.

Authors:  L Symon; R J Harris; N M Branston
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

10.  Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.

Authors:  R P Hof
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.